A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister

preview_player
Показать описание
Recorded on February 2nd, 2023 as part of the Immunotherapy Treatment Chapter in the Myeloma Community Program by HealthTree with Dr. Craig Hofmeister.

Follow HealthTree:
Рекомендации по теме
Комментарии
Автор

This has been extremely educational by this webinar. Thank you

MarthaGarrett
Автор

Thank you, I’m an ER physician who has recently been diagnosed of multiple myeloma. This helps on my treatment.

asimraja
Автор

really clear presentation. Dr. Hofmeister has presented the current landscape of the CAR-T treatment in a simple manner. Thank you!

genekim
Автор

I am both intrigued and excited about the outcome possible after CarT?

MarthaGarrett
Автор

The future is with CAR-NK cells, T cells have an important role to play, but Mother Nature and the immune system, designated NK cells to provide surveillance and protection against cancer and they can collaborate very closely with the other lymphocytes like B and T cells, T cells are indispensable helpers of the NK cells.

josealvarez
Автор

Using T cells as if they were NK cells, will slow progress very much.

josealvarez